Trial
NCT02524951
Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Northwell Health
Collaborators
DepYmed Inc.
Condition
Metastatic Breast Cancer
Intervention
MSI-1436C
Why stopped
lack of interest by sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-18